The session will focus on the quality and operational vulnerabilities that often surface during the clinical‑to‑commercial transition – especially the risks that become visible only when organizations begin to scale. I’ll be covering three core areas:

• Data integrity gaps that emerge in the transition to commercial
• Audit readiness challenges, including the shift from reactive prep to continuous inspection readiness
• System and process weaknesses exposed during scale-up